Commercial growth remains dependent on shifting Rytelo use earlier, with management targeting 2026 but offering no specific revenue guidance.
| Quarter | Q3 FY25 |
|---|---|
| Length | 39 minutes |
| EPS | $-0.03 |
| EPS consensus | $-0.03 |
What changed, guidance prior to now, analyst Q&A candor and the case for and against are part of Core.
Other quarters: Q2 FY26 · Q2 FY25 · Q1 FY25
Read the full Q3 FY25 earnings call transcript
All GERN earnings · Back to GERN overview
Transcript produced by Signals.AI from the company's own earnings call audio. Not personalized investment advice.